Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer | NEJM
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Cancer Research and Treatment
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis - The
A) Overall survival (OS) from study entry of all eligible patients... | Download Scientific Diagram
Outcomes and endpoints in trials of cancer treatment: the past, present, and future - The Lancet Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
Endpoints Used in Clinical Trials Endpoint Definition Overall survival... | Download Table
PPT - Overall Survival and Progression-Free Survival PowerPoint Presentation - ID:4064400
![PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30f4b9adffa198bf79a177643e74ec64b4107203/3-Table1-1.png "PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar")
PDF] Incorporating Clinical Trial Data Into Daily Cancer Care | Semantic Scholar
JCM | Free Full-Text | Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy
Survival in oncology reimbursement decision-making | CMAR
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer | Journal of Clinical Oncology
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials - Matulonis - 2015 - Cancer - Wiley Online Library
Endpoints in adjuvant trials: a systematic review of the literature in colon cancer and proposed definitions for future trials Marc E. Buyse. - ppt download
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Margin status and survival outcomes after breast cancer conservation surgery: prospectively registered systematic review and meta-analysis | The BMJ
Estimating progression-free survival in patients with glioblastoma using routinely collected data | SpringerLink
Kaplan–Meier plots for overall survival among patients who were... | Download Scientific Diagram
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | SpringerLink
A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials | Radiology: Imaging Cancer
Time to second subsequent therapy as an endpoint. Progression-free... | Download Scientific Diagram
Clinical Trial Endpoints for Oncology Studies
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 | Journal of Clinical Oncology
